These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37993863)

  • 1. Relationship between glucocorticoids and viral load during the Omicron wave in mainland China.
    Bai G; Li Y; Liu Y; Wang X; Yu X; Ren L; Xu J
    Virol J; 2023 Nov; 20(1):273. PubMed ID: 37993863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China.
    Yang Y; Guo L; Yuan J; Xu Z; Gu Y; Zhang J; Guan Y; Liang J; Lu H; Liu Y
    Lancet Microbe; 2023 Aug; 4(8):e632-e641. PubMed ID: 37459867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
    Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
    Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.
    Ricciotti E; Laudanski K; FitzGerald GA
    Adv Biol Regul; 2021 Aug; 81():100818. PubMed ID: 34303107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
    Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
    Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
    Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
    Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections.
    Liu J; Wen R; Wang N; Li G; Xu P; Li X; Zeng X; Liu C
    Int J Med Sci; 2024; 21(3):454-463. PubMed ID: 38250611
    [No Abstract]   [Full Text] [Related]  

  • 10. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
    Masiá M; Fernández-González M; Padilla S; Ortega P; García JA; Agulló V; García-Abellán J; Telenti G; Guillén L; Gutiérrez F
    EBioMedicine; 2020 Oct; 60():102999. PubMed ID: 32950003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
    Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
    Front Immunol; 2022; 13():811430. PubMed ID: 35250984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak.
    Ren GL; Wang XF; Xu J; Li J; Meng Q; Xie GQ; Huang B; Zhu WC; Lin J; Tang CH; Ye S; Li Z; Zhu J; Tang Z; Ma MX; Xie C; Wu YW; Liu CX; Yang F; Zhou YZ; Zheng Y; Lan SL; Chen JF; Ye F; He Y; Wu BQ; Chen L; Fu SM; Zheng CZ; Shi Y
    Mil Med Res; 2021 Feb; 8(1):13. PubMed ID: 33593415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    Gottlieb RL; Nirula A; Chen P; Boscia J; Heller B; Morris J; Huhn G; Cardona J; Mocherla B; Stosor V; Shawa I; Kumar P; Adams AC; Van Naarden J; Custer KL; Durante M; Oakley G; Schade AE; Holzer TR; Ebert PJ; Higgs RE; Kallewaard NL; Sabo J; Patel DR; Klekotka P; Shen L; Skovronsky DM
    JAMA; 2021 Feb; 325(7):632-644. PubMed ID: 33475701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronological changes of viral shedding in adult inpatients with Omicron infection in Shanghai, China.
    Zhou X; Huang X; Sun T; Jin X; Tian Z; Xue M; Kang J; Gao B; Xu A; Chen Y; Jia Y; Liu S
    Front Immunol; 2023; 14():1090498. PubMed ID: 36817453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children's medical center in Shanghai, China.
    Shen N; Wu YF; Chen YW; Fang XY; Zhou M; Wang WY; Tang MY; Pan QH; Ma J; Zhang H; Cao Q
    World J Pediatr; 2023 Jan; 19(1):87-95. PubMed ID: 36251118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid quantification for COVID-19: A retrospective study of >3000 COVID-19 patients from 2 centers.
    Wu Z; Yang C; Shen Y; Zhang Q; Tang X; Wang D; Xu Y; Cao G; Song X; Ma Y; Fan H; Lu H; Li Y; Li X; Shen Y; Zhang C; Zhu M; Teng X; Du Y; Guan M
    Clin Chim Acta; 2023 Feb; 540():117227. PubMed ID: 36640930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
    Zheng S; Fan J; Yu F; Feng B; Lou B; Zou Q; Xie G; Lin S; Wang R; Yang X; Chen W; Wang Q; Zhang D; Liu Y; Gong R; Ma Z; Lu S; Xiao Y; Gu Y; Zhang J; Yao H; Xu K; Lu X; Wei G; Zhou J; Fang Q; Cai H; Qiu Y; Sheng J; Chen Y; Liang T
    BMJ; 2020 Apr; 369():m1443. PubMed ID: 32317267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New characteristics of COVID-19 caused by the Omicron variant in Guangzhou].
    Cheng LL; Li SY; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 May; 46(5):441-443. PubMed ID: 37147805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.